Search

Your search keyword '"Marc-Henri Stern"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Marc-Henri Stern" Remove constraint Author: "Marc-Henri Stern"
303 results on '"Marc-Henri Stern"'

Search Results

1. Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp

2. Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma

3. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation

4. Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement

5. Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers

6. Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma

7. Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency

8. A catalog of numerical centrosome defects in epithelial ovarian cancers

9. The association between genetically elevated polyunsaturated fatty acids and risk of cancerResearch in context

10. A DNA methylation-based liquid biopsy for triple-negative breast cancer

11. Ultraviolet radiation drives mutations in a subset of mucosal melanomas

12. Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution

13. Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer

14. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors

15. A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus

16. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

17. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

18. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

19. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

20. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

21. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

22. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

23. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

24. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

25. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

26. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

27. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

28. Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

29. STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model

30. Genomic Signature of Homologous Recombination Deficiency in Breast and Ovarian Cancers

31. The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.

32. Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy

33. Abstract P6-10-05: Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition

34. Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial

35. Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma

36. The association between genetically elevated polyunsaturated fatty acids and risk of cancer

37. FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma

39. Supplementary Tables 1-12 from SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma

40. Data from Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

41. Supplementary Figures S1-S7 from SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma

42. Supplementary Figure from Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

43. Supplementary Table from Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

44. Supplementary Data from Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

45. Data from Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations

46. Data from Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma

47. Figure S6 from Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations

48. Figure S3 from Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA

50. Supplementary Figure 1 from Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma

Catalog

Books, media, physical & digital resources